Sign Up to like & get
recommendations!
0
Published in 2020 at "Advances in experimental medicine and biology"
DOI: 10.1007/978-3-030-41008-7_7
Abstract: Patients with advanced and/or recurrent gynecologic cancers derive limited benefit from currently available cytotoxic and targeted therapies. Successes of immunotherapy in other difficult-to-treat malignancies such as metastatic melanoma and advanced lung cancer have led to…
read more here.
Keywords:
gynecologic cancers;
immuno oncology;
oncology gynecologic;
cancer ... See more keywords